Associate Professor Christopher Etherton-Beer

Started at UWA: 2004

Improving the lives of those with dementia

There is sparse guidance relating to managing medications to treat other chronic conditions for people living with dementia. My goal is to change this.
Associate Professor Christopher Etherton-Beer

Christopher Etherton-Beer is an Associate Professor in Geriatric Medicine at UWA, researching dementia and related chronic conditions. His research has led him to develop an organisational resource called Towards Organisational Culture Change (TOrCCh) to be used in aged care homes.

With the elderly expected to make up nearly a quarter of Australia’s population by 2056, the TOrCCh resource is needed now more than even to assist aged care staff in improving their services.

Professor Etherton-Beer is also looking at the guidelines surrounding medications the elderly are taking and ways to optimise their use in conjunction with dementia. His other research specialisations are pharmaco-geriatrics, strokes, and medical education.

When undertaking his research, Professor Etherton-Beer works closely with the WA Centre for Health and Ageing within the Harry Perkins Institute of Medical Research on the UWA Health Campus.

Aside from his active research, he is a geriatrician and clinical pharmacologist at Royal Perth Hospital, and serves on the Federal Council of the Australian and New Zealand Society for Geriatric Medicine, the Pharmaceutical Benefits Advisory Committee, and the board of aged care service provider Juniper.

Professor Etherton-Beer is the past chair of the Royal Australasian College of Physicians Advanced Training Committee in Geriatric Medicine, and present Chair of the Western Australian Therapeutics Advisory Group. At UWA, he co-ordinates, with Professor Leon Flicker, the University’s geriatric medicine teaching within the Medical School.

award Created with Sketch.

Senior Advocate Award, 2015

008-trophy Created with Sketch.

Research award for Best Completed Research Abstract at SimHealth, 2016

medal Created with Sketch.

Joint winner, Outstanding Contribution to Student Learning, UWA Faculty of Medicine, Dentistry and Health Science Excellence in Teaching Awards, 2017



2018 – 2020

National Health and Medical Research Council

  • BAN-Dep: A trial to decrease the prevalence of depression in Australian Nursing Homes
  • Almeida, O., Etherton-Beer, C., Flicker, L. and Ford, A.

National Health and Medical Research Council

  • Team Approach to Polypharmacy Evaluation and Reduction for General Practice patients with dementia: the Australian TAPERdem study.
  • Etherton-Beer, C., Clifford, R. & Page, A.

2018 – 2019

WA Health Promotion Foundation Healthway

  • Strengthening Consumer Voice: Using stories to shift mental illness stigma
  • Seubert, L., Brand, G., Clifford, R. & Etherton-Beer, C.


WA Department of Health

  • MHRIF Round 21 - Christopher Etherton-Beer
  • Etherton-Beer, C.

Worldwide Universities Network

  • Sustainability Fund Grant - A Social Care Approach to Ageing: Extending the WUN global initiative promoting meaningful engagement of persons with advanced dementia ageing in supported living environments
  • Baldassar, L. & Etherton-Beer, C.

Pharmaceutical Society of Western Australia

  • The PHarmacie-4 Framework: Using risk stratification and care coordination to bridge the care continuum gap
  • Clifford, R., Criddle, D., Etherton-Beer, C., Murray, K., Sanfilippo, F. & Smart, P.

2017 – 2021

National Health and Medical Research Council

  • Reaching the tenth decade of life in Australia – A 20-year longitudinal study of older men
  • Flicker, L., Almeida, O., Etherton-Beer, C., McCaul, K. & Yeap, B.

2017 – 2019

WA State Health Research Advisory Council

  • RTP - Round 11 - The Australian Team Approach to Polypharmacy Evaluation and Reduction (AusTAPER) study for older hospital inpatients
  • Etherton-Beer, C., Clifford, R. & Page, A.

2014 – 2018

University of Sydney

  • Centre of Research Excellence in Medicines and Ageing
  • Preen, D. & Etherton-Beer, C.

National Health and Medical Research Council

  • An Australasian, multi-centre, randomized, double-blind, placebo-controlled trial of the efficacy of fluoxetine in improving functional recovery after acute stroke / Assessment of FluoxetINe In sTroke recoverY (AFFINITY)
  • Hankey, G., Almeida, O., Etherton-Beer, C., Flicker, L. & Ford, A.

Contact Associate Professor Christopher Etherton-Beer